Radioprotection by antioxidants

Annals of the New York Academy of Sciences

Volumn 899, Issue , 2000, Pages 44-60

  Weiss, Joseph F ^a   Landauer, Michael R ^b  

^a U S DEPARTMENT OF ENERGY   (United States)

^b ARMED FORCES RADIOBIOLOGY RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; AMIFOSTINE; ANTIOXIDANT; METHYLXANTHINE DERIVATIVE; NIMODIPINE; PHOSPHOROTHIOIC ACID DERIVATIVE; PHOSPHOROTHIOIC ACID S 3 (3 METHYLAMINOPROPYLAMINO)PROPYL ESTER; PROPRANOLOL; REACTIVE OXYGEN METABOLITE; SELENIUM; SUPEROXIDE DISMUTASE; THIOL;

ANTIOXIDANT ACTIVITY; CONFERENCE PAPER; RADIATION INJURY; RADIATION PROTECTION; RADIOTHERAPY;

EID: 0034046590     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06175.x     Document Type: Conference Paper

References (99)

1. 1. PATT, H.M., E.B. TYREE, R.L. STRAUBE & D.E. SMITH. 1949. Cysteine protection against x-irradiation. Science 110: 213-214.
2. 2. GERSCHMAN, R., D.L. GILBERT, S.W. NYE, P. DWYER & W.O. FENN. 1954. Oxygen poisoning and x-irradiation: A mechanism in common. Science 119: 623-626.
3. 3. SWEENEY, T.R. 1979. A Survey of Compounds from the Antiradiation Drug Development Program of the U.S. Army Medical Research Development Command, Walter Reed Army Institute of Research, Washington, DC.
4. 4. WEISS, J.F. 1997. Pharmacologic approaches to protection against radiation-induced lethality and other damage. Environ. Health Perspect. 105 (Suppl. 6): 1473-1478.
5. 5. MURRAY, D. & W.H. MCBRIDE. 1996. Radioprotective agents. In Kirk-Othmer Encyclopedia of Chemical Technology, Fourth edition, Vol. 20: 963-1006. John Wiley & Sons, New York, NY.
6. 6. MITCHELL, J.M., A. RUSSO, P. KUPPUSAMY & M.C. KRISHNA. 2000. Radiation, radicals, and images. Ann. N.Y. Acad. Sci. 899: this volume.
7. 7. BROWN, D.Q., W.J. GRAHAM, L.J. MACKENSIE, J.W. PITTOCK & L. SHAW. 1988. Can WR-2721 be improved upon? Pharmac. Ther. 39: 157-168.
8. 8. WEISS, J.F., M.R. LANDAUER, P.J. GUNTER-SMITH & W.R. HANSON. 1995. Effect of radioprotective agents on survival after acute intestinal radiation injury. In Radiation and the Gastrointestinal Tract. A. Dubois, G.L. King & D.R. Livengood, Eds. :183-199. CRC Press. Boca Raton, FL.
9. 9. LANDAUER, M.R., H.D. DAVIS, JA. DOMINITZ & J.F. WEISS. 1988. Long-term effects of the radioprotector WR-2721 on locomotor activity and body weight of mice following exposure to ionizing radiation. Toxicology 49: 315-323.
10. 10. LANDAUER, M.R., H.D. DAVIS, J.A. DOMINITZ & J.F. WEISS. 1987. Dose and time relationships of the radioprotector WR-2721 on locomotor activity in mice. Pharmacol. Biochem. Behavior 27: 573-576.
11. 11. LANDAUER, M.R., H.D. DAVIS, K.S. KUMAR & J.F. WEISS. 1992. Behavioral toxicity of selected radioprotectors. Adv. Space Res. 12(2): 273-283.
12. 12. CAPIZZI, R.L. & W. OSTER. 1995. Protection of normal tissue from the cytotoxic effects of chemotherapy and radiation by amifostine: clinical experience. Eur. J. Cancer 31A, (Suppl 1): S8-S13.
13. 13. LANDAUER, M.R., H.D. DAVIS, J.A. DOMINITZ & J.F. WEISS. 1988. Comparative behavioral toxicity of four sulfhydryl radioprotective compounds in mice: WR-2721, cysteamine, diethyldithiocarbamate and N-acetylcysteine. Pharmac. Ther. 39: 97-100.
14. 14. WEISS, J.F., V. SRINIVASAN, A.J. JACOBS & W. A. RANKIN. 1984. Effect of sulfur compounds on radiation-induced suppression of delayed-type hypersensitivity to oxazolone in mice. Proc. Am. Assoc. Cancer Res. 25: 235.
15. 15. SRINIVASAN, V. & J.F. WEISS. 1984. Suppression of delayed-type hypersensitivity to oxazolone in whole-body-irradiated mice and protection by WR-2721. Radiat. Res. 98: 438-444.
16. 16. RENOUX, G. & M. RENOUX. 1977. Thymus-like activities of sulphur derivatives on T-cell differentiation. J. Exp. Med. 145: 466-471.
17. 17. HEIKKILA, R.E., F.S. CABBAT & G. COHEN. 1976. In vivo inhibition of superoxide dismutase in mice by diethyldithiocarbamate. J. Biol. Chem. 251: 2182-2185.
18. 18. KUMAR, K.S., A.M. SANCHO & J.F. WEISS. 1986. A novel interaction of diethyldithiocarbamate with the glutathione/glutathione peroxidase system. Int. J. Radiat. Oncol. Biol. Phys. 12: 1463-1467.
19. 19. EVANS, R.G. 1985. Tumor radiosensitization with concomitant bone marrow radioprotection: a study in mice using diethyldithiocarbamate (DDC) under oxygenated and hypoxic conditions. Int. J. Radiat. Oncol. Biol. Phys. 11: 1163-1169.
20. 20. UMA DEVI, P. & B. THOMAS. 1988. Bone marrow cell protection and modification of drug toxicity by combination of protectors. Pharmac. Ther. 39: 213-214.
21. 21. MAISIN, J. R. 1998. Chemical radioprotection: past, present and future prospects. Int. J. Radiat. Biol. 73: 443-450.
22. 22. MURLEY, J.S. & D.J. GRDINA. 1998. Chemoprevention with WR-2721 and its metabolites. In Radioprotectors: Chemical, Biological, and Clinical Perspectives. E.A. Bump & K. Malaker, Eds. :299-313. CRC Press. Boca Raton, FL.
23. 23. MILAS, L., N. HUNTER, L.C. STEPHENS & L.J. PETERS. 1984. Inhibition of radiation carcinogenesis in mice by S-2-(3-aminopropylamino)-ethylphosphorothioic acid. Cancer. Res. 44: 5567-5569.
24. 24. GRDINA, D.J, B.J. WRIGHT & B.A. CARNES. 1991. Protection by WR-151327 against late-effect damage from fission-spectrum neutrons. Radiat. Res. 128: S124-S127.
25. 25. HOLWITT, E.A., E. KODA & C.E. SWENBERG. 1990. Enhancement of topoisomerase I-mediated unwinding of supercoiled DNA by the radioprotector WR-33278. Radiat. Res. 124: 107-109.
26. 26. SAVOYE, C., C. SWENBERG, S. HUGOT, D. SY, R. SABATTIER, M. CHARLIER & M. SPOTHEIM-MAURIZOT. 1997. Thiol WR-1065 and disulphide WR-33278, two metabolites of the drug Ethyol (WR-2721), protect DNA against fast neutron-induced strand breakage. Int. J. Radiat. Biol. 71: 193-202.
27. 27. GRDINA, D.J., N. SHIGEMATSU, P. DALE, G.L. NEWTON, J.A. AGUILERA & R.C. FAHEY. 1995. Thiol and disulfide metabolites of the radiation protector and potential chemopreventive agent WR-2721 are linked to both its anti-cytotoxic and anti-mutagenic mechanisms of action. Carcinogenesis 16: 767-774.
28. 28. MITCHELL, J. L., J. RUPERT. A. LEYSER & G. G. JUDD. 1998. Mammalian cell polyamine homeostasis is altered by the radioprotector WR1065. Biochem. J. 335: 329-334.
29. 29. DRAB-WEISS, E.A., I.K. HANSRA, E.R. BLAZEK & D.B. RUBIN. 1998. Aminothiols protect endothelial cell proliferation against inhibition by lipopolysaccharide. Shock 10: 423-429.
30. 30. KUNA, P., K. VOLENEC, I. VODICKA & M. DOSTAL. 1983. Radioprotective and hemodynamic effects of WR-2721 and cystamine in rats: time course studies. Neoplasma 30: 349-357.
31. 31. RYAN, S.V., S.L. CARRITHERS, S.J. PARKINSON, C. SKURK, C. NUSS, P.M. POOLER, C.S. OWEN, A.M. LEFER & S.A. WALDMAN. 1996. Hypotensive mechanisms of amifostine. J. Clin. Pharmacol. 36: 365-373.
32. 32. WEISS, J.F. & K.S. KUMAR. 1988. Antioxidant mechanisms in radiation injury and radioprotection. In Cellular Antioxidant Defense Mechanisms, Vol. II. C.K. Chow, Ed. :163-189. CRC Press. Boca Raton, FL.
33. 33. WEISS, J.F., K.S. KUMAR, T.L. WALDEN, R. NETA, M.R. LANDAUER & E.P. CLARK. 1990. Advances in radioprotection through the use of combined agent regimens. Int. J. Radiat. Biol. 57: 709-722.
34. 34. SORENSON, J.R. 1992. Essential metalloelement metabolism and radiation protection and recovery. Radiat. Res. 132: 19-29.
35. 35. WEISS, J.F., V. SRINIVASAN, K.S. KUMAR, M.R. LANDAUER & M.L. PATCHEN. 1994. Radioprotection by selenium compounds. In Trace Elements and Free Radicals in Oxidative Diseases. A.E. Favier, J. Neve J & P. Fauve, Eds. :211-222. AOCS Press, Champaign, IL.
36. 36. SRINIVASAN, V., K.S. KUMAR & J.F. WEISS. 1991. Radioprotection by metals: Zinc. Radiation Research: A Twentieth-Century Perspective, Vol. I: Congress Abstracts. J.D. Chapman, W.C. Dewey & G.F. Whitmore, Eds. :369. Academic Press, San Diego, CA.
37. 37. PETKAU, A. 1987. Role of superoxide dismutase in modification of radiation injury. Brit. J. Cancer 55 (Suppl. VIII): 87-95.
38. 38. SEIFTER, E., G. RETTURA, J. PADAWER, F. STRATFORD, J. WEINZWEIG, A.A. DEMETRIOU & S.M. LEVENSON. 1984. Morbidity and mortality reduction by supplemental vitamin A or β-carotene in CBA mice given total body γ-radiation. J. Natl. Can. Inst. 73: 1167-1177.
39. 39. ROY, R.M., M. PETRELLA & H. SHATERI. 1988. Effects of administering tocopherol after irradiation on survival and proliferation of murine lymphocytes. Pharmac. Ther. 39: 393-395.
40. 40. RAMAKRISHNAN, N.N., W.W. WOLFE & G.N. CATRAVAS. 1992. Radioprotection of hematopoietic tissues in mice by lipoic acid. Radiat. Res. 130: 360-365.
41. 41. VIJAYALAXMI, R. J. REITER, M. L. MELTZ & T. S. HERMAN. 1998. Melatonin: possible mechanisms involved in its 'radioprotective' effect. Mutat. Res. 404: 187-189.
42. 42. WHITNALL, M.H., T.B. ELLIOTT, M.R. LANDAUER, C.L. WILHELMSEN, K.S. KUMAR, V. SRINIVASAN, W.E. JACKSON, G.D. LEDNEY & T.M. SEED. 1999. 5-Androstenediol as a radioprotectant. FASEB J. 13: A636.
43. 43. BLUMENTHAL, M. 1998. The Complete German Commission E Monographs. Therapeutic Guide to Herbal Medicines. American Botanical Council, Integrative Medicine Communications. Austin, TX.
44. 44. UMA DEVI, P., K.S. BISHT & M. VINITHA. 1998. A comparative study of radioprotection by Ocimum flavinoids and synthetic aminothiol protectors in the mouse. Br. J. Radiol. 71: 782-784.
45. 45. UMA DEVI, P., A. GANASOUNDARI, B.S.S. RAO & K.K. SRINIVASAN. 1999. In vivo radioprotection by Ocimum flavinoids: survival of mice. Radiat. Res. 151: 74-78.
46. 46. RAMAKRISHNAN, N., J.F. KALINICH & D.E. MCCLAIN. 1998. Radiation-induced apoptosis in lymphoid cells: Induction, prevention, and molecular mechanisms. In Radioprotectors: Chemical, Biological, and Clinical Perspectives. E.A. Bump & K. Malaker, Eds. :253-273. CRC Press. Boca Raton, FL.
47. 47. KONINGS, A.W., J. DAMEN & W.B. TRIELING. 1979. Protection of liposomal lipids against radiation induced oxidative damage. Int. J. Radiat. Biol. Stud. Phys. Chem. Med. 35: 343-350.
48. 48. KROLAK, J.M., H. MAY, R.L. HOOVER & J.F. WEISS. 1986. Effect of nutritional supplements on postirradiation survival of mice. Presented at the Twenty-fifth Hanford Life Science Symposium, Radiation Protection - A Look to the Future, Richland, WA.
49. 49. SRINIVASAN, V., A.J. JACOBS, S.A. SIMPSON & J.F. WEISS. 1983. Radioprotection by vitamin E: effects on hepatic enzymes, delayed type hypersensitivity and postirradiation survival of mice. In Modulation and Mediation of Cancer by Vitamins. F.L. Meyskens & K.N. Prasad, Eds. :119-131. Karger. Basel.
50. th International Congress of Radiation Research. J.J. Broerse, G.W. Barendsen, H.B. Kal & A.J. van der Kogel, Eds. :D5-15. Martinus Nijhoff Publishers, Amsterdam.
51. 51. SANDSTROM, B. E., J. CARLSSON & S. L. MARKLUND. 1989. Selenite-induced variation in glutathione peroxidase activity of three mammalian cell lines: no effect on radiation-induced cell killing or DNA strand breakage. Radiat. Res. 117: 318-325.
52. 52. CHOW, C.K. 1988. Interrelationships of cellular antioxidant defense systems. In Cellular Antioxidant Defense Mechanisms, Vol. II. C.K. Chow, Ed. :217-237. CRC Press. Boca Raton, FL.
53. 53. KUMAR, K. S., Y. N. VAISHNAV & J. F. WEISS. 1988. Radioprotection by antioxidant enzymes and enzyme mimetics. Pharmac. Ther. 39: 301-309.
54. 54. SUN, J., Y. CHEN, M. LI & Z. GE. 1998. Role of antioxidant enzymes on ionizing radiation resistance. Free Radic. Biol. Med. 24: 586-593.
55. 55. SCOTT, M.D., S.R. MESHNICK & J.W. EATON. 1989. Superoxide dismutase amplifies organismal sensitivity to ionizing radiation. J. Biol. Chem. 264: 2498-2501.
56. 56. YAMAOKA, K., S. KOJIMA, M. TAKAHASHI, T. NOMURA & K. IRIYAMA. 1998. Change of glutathione peroxidase synthesis along with that of superoxide dismutase synthesis in mice spleens after low-dose X-ray irradiation. Biochim. Biophys. Acta 1381: 265-270.
57. 57. NETA, R., J.J. OPPENHEIM & S.D. DOUCHES. 1988. Interdependence of the radioprotective effects of human recombinant interleukin 1, tumor necrosis factor, granulocyte colony-stimulating factor, and murine recombinant granulocyte-macrophage colony stimulating factor. J. Immunol. 140: 108-111.
58. 58. NETA, R. 1997. Insights into the mechanisms of radiation damage and radioprotection through their modulation by cytokines. Environ. Health Perspect. 105(Suppl. 6): 1463-1465.
59. th Annual Meeting of the Radiation Research Society. :185. Nashville, TN.
60. 60. MASUDA, A., D.L. LONGO, Y. KOBAYASHI, E. APPELLA, J.J. OPPENHEIM & K. MATSUSHIMA. 1988. Induction of mitochondrial manganese superoxide dismutase by interleukin 1. FASEB J. 2: 3087-3091.
61. 61. WONG, G.H. 1995. Protective roles of cytokines against radiation: induction of mitochondrial MnSOD. Biochim. Biophys. Acta 1271: 205-209.
62. 62. WESTMAN, N.G. & S.L. MARKLUND. 1981. Copper-and zinc-containing superoxide dismutase and manganese-containing superoxide dismutase in human tissues and human malignant tumors. Cancer Res. 41: 2962-2966.
63. 63. OBERLEY, T. D. & L. W. OBERLEY. 1997. Antioxidant enzyme levels in cancer. Histol. Histopathol. 12: 525-535.
64. 64. EPPERLY, M., J. BRAY, S. KRAEGER, R. ZWACKA, J. ENGELHARDT, E. TRAVIS & J. GREENBERGER. 1998. Prevention of late effects of irradiation lung damage by manganese superoxide dismutase gene therapy. Gene Ther. 5: 196-208.
65. 65. KONOPACKA, M., M. WIDEL & J. RZESZOWSKA-WOLNY. 1998. Modifying effect of vitamin C, E and beta-carotene against gamma-ray-induced DNA damage in mouse cells. Mutat. Res. 417: 85-94.
66. 66. SARMA, L. & P.C. KESAVAN. 1993. Protective effects of vitamins C and E against gamma-ray-induced chromosomal damage in mouse. Int. J. Radiat. Biol. 63: 759-764.
67. 67. DIAMOND, A.M., P. DALE, J.L. MURRAY & D.J. GRDINA. 1996. The inhibition of radiation-induced mutagenesis by the combined effects of selenium and the aminothiol WR-1065. Mutat. Res. 23: 147-154.
68. 68. BOREK, C., A. ONG, H. MASON, L. DONAHUE & J.E. BIAGLOW. 1986. Selenium and vitamin E inhibit radiogenic and chemically induced transformation in vitro via different mechanisms. Proc. Natl. Acad. Sci. USA 83: 1490-1494.
69. 69. KENNEDY, A.R. 1984. Prevention of radiation transformation in vitro. In Vitamins, Nutrition and Cancer. K.N. Prasad, Ed. :166-179. Karger. Basel.
70. 70. ST. CLAIR, D.K., X.S. WAN, T.D. OBERLEY, K.E. MUSE & W.H. ST. CLAIR. 1992. Suppression of radiation-induced neoplastic transformation by overexpression of mitochondrial superoxide dismutase. Mol. Carcinogen. 6: 238-242.
71. 71. BERTRAM, J.S., L.N. KOLONEL & F.L. MYSKENS. 1987. Rationale and strategies for chemoprevention of cancer in humans. Cancer Res. 47: 3012-3031.
72. 72. KELLOFF, G.J., C.W. BOONE, J.A. CROWELL, V.E. STEELE, R.A. LUBET, L.A. DOODY, W.F. MALONE, E.T. HAWK & C.C. SIGMAN. 1996. New agents for cancer chemoprevention. J. Cell Biochem. Suppl. 26: 1-28.
73. 73. KELLOFF, G.J., E.T. HAWK, J.E. KARP, J.A. CROWELL, C.W. BOONE, V.E. STEELE, R.A. LUBET & C.C. SIGMAN. 1997. Progress in clinical chemoprevention. Semin. Oncol. 24: 241-252.
74. 74. ALBANES, D., O.P. HEINONEN, J.K. HUTTUNEN, P.R. TAYLOR, J. VIRTAMO, B.K. EDWARDS, J. HAAPAKOSKI, M. RAUTALAHTI, A.M. HARTMAN, J. PALMGREN et al. 1995. Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study. Am. J. Clin. Nutr. 62 (Suppl. 6): 1427S-1430S.
75. 75. COMBS, G.F., L.C. CLARK & B.W. TURNBULL. 1997. Reduction of cancer risk with an oral supplement of selenium. Biomed. Environ. Sci. 10: 227-234.
76. 76. EMERIT, I., N. OGANESIAN, T. SARKISIAN, R. ARUTYUNYAN, A. POGOSIAN, K. ASRIAN, A. LEVY & L. CERNJAVSKI. 1995. Clastogenic factors in the plasma of Chernobyl accident recovery workers: anticlastogenic effect of Ginkgo biloba extract. Radiat. Res. 144: 198-205.
77. 77. EMERIT, I., M. QUASTEL, J. GOLDSMITH, L. MERKIN, A. LEVY, L. CERNJAVSKI, A. ALAOUI-YOUSSEFI, A. POGOSIAN & E. RIKLIS. 1997. Clastogenic factors in the plasma of children exposed at Chernobyl. Mutat. Res. 373: 47-54.
78. 78. EMERIT, I., N. OGANESIAN, R. ARUTYUNIAN, A. POGOSSIAN, T. SARKISIAN, L. CERNJAVSKI, A. LEVY & J. FEINGOLD. 1997. Oxidative stress-related clastogenic factors in plasma from Chernobyl liquidators: protective effects of antioxidant plant phenols, vitamins and oligoelements. Mutat. Res. 377: 239-246.
79. 79. BEN-AMOTZ, A., S. YATZIV, M. SELA, S. GREENBERG, B. RACHMILEVICH, M. SHWARZMAN & Z. WESHLER. 1998. Effect of natural beta-carotene supplementation in children exposed to radiation from the Chernobyl accident. Radiat. Environ. Biophys. 37: 187-193.
80. 80. KOYAMA, S., S. KODAMA, K. SUZUKI, T. MATSUMOTO, T. MIYAZAKI & M. WATANABE. 1998. Radiation-induced long-lived radicals which cause mutation and transformation. Mutat. Res. 421: 45-54.
81. 81. WU, L. J., G. RANDERS-PEHRSON, A. XU, C. A. WALDREN, C. R. GEARD, Z. YU & T. K. HEI. 1999. Targeted cytoplasmic irradiation with alpha particles induces mutations in mammalian cells. Proc. Natl. Acad. Sci. USA 96: 4959-4964.
82. 82. DRUG INFORMATION. 1999. American Hospital Formulary Service, American Society of Health-System Pharmacists, Bethesda, MD.
83. 83. MACPHAIL, R.C., D.B. PEELE & K.M. CROFTON. 1989. Motor activity and screening for neurotoxicity. J. Amer. Coll. Toxicol. 8: 117-125.
84. 84. LANDAUER, M.R., J.B. HOGAN, C.A. CASTRO, K.A. BENSON, C.W. SHEHATA & J.F. WEISS. 1996. Behavioral toxicity and radioprotective efficacy of WR-151327 in combination with adenosine receptor antagonists. In Proceedings of the 1995 ERDEC Scientific Conference on Chemical and Biological Defense Research. D.A. Berg, Ed. :665-669. Research and Technology Directorate. Aberdeen Proving Ground, MD.
85. 85. LEHNERT, S. 1979. Radioprotection of mouse intestine by inhibitors of cyclic AMP phosphodiesterase. Int. J. Radiat. Oncol. Biol. Phys. 5: 825-833.
86. 86. WEISS, J.F., M.R. LANDAUER, J.B. HOGAN, P.J. GUNTER-SMITH, K.A. BENSON, R. NETA & W.R. HANSON. 1997. Modification of radiation-induced gastrointestinal and hematopoietic injury in mice by combinations of agents: effects of indomethacin and caffeine. Adv. Exp. Med. Biol. 400B: 865-872.
87. 87. FAROOQUI, Z. & P. C. KESAVAN. 1992. Radioprotection by caffeine pre-and post treatment in the bone marrow chromosomes of mice given whole-body γ-irradiation. Mutat. Res. 269: 225-230.
88. 88. GEORGE, K.C., S.A. HEBBAR, S.P. KALE & P.C. KESAVAN. 1999. Caffeine protects mice against whole-body lethal dose of gamma-irradiation. J. Radiol. Prot. 19: 171-176.
89. 89. STELZER K. J., W-J. KOH, H. KURTZ, B. E. GREER & T. W. GRIFFIN. 1994. Caffeine consumption is associated with decreased severe late toxicity after radiation to the pelvis. Int. J. Radiat. Oncol. Biol. Phys. 30: 411-417.
90. 90. DION, M.W., D.H. HUSSEY & J.W. OSBORNE. 1989. The effect of pentoxifylline on early and late radiation injury following fractionated irradiation in C3H mice. Int. J. Radiat. Oncol. Biol. Phys. 17: 101-107.
91. 91. POSPISIL M., M. HOFER, J. NETIKOVA, I. PIPALOVA, A. VACEK, A. BARTONICKOVA & K. VOLENEC. 1993. Elevation of extracellular adenosine induces radioprotective effects in mice. Radiat. Res. 134: 323-330.
92. 92. UEDA, T., Y. TOYOSHIMA, T. MORITANI, K. RI, N. OTSUKI, T. KUSHIHASHI, H. YASUHARA & T. HISHIDA. 1996. Protective effect of dipyridamole against lethality and lipid peroxidation in liver and spleen of the ddY mouse after whole-body irradiation. Int. J. Radiat. Biol. 69: 199-204.
93. 93. MAK, I.T. & W.B. WEGLICKI. 1992. Membrane antiperoxidative activities of D-propranolol, L-propranolol and dimethyl quaternary propranolol (UM-272). Pharmacol. Res. 25: 25-30.
94. 94. MAK, I.T. & W.B. WEGLICKI. 1990. Comparative antioxidant activities of propranolol, nifedipine, verapamil, and diltiazem against sarcolemmal membrane lipid peroxidation. Circ. Res. 66: 1449-1452.
95. nd Annual Meeting of the Radiation Research Society. :211. Nashville, TN.
96. 96. LANDAUER, M.R., C.A. CASTRO, K.A. BENSON, J.B. HOGAN & J.F. WEISS. 1997. Radiation protection and locomotor performance with a combination of calcium antagonist and a phosphorothioate. In Proceedings of the 1996 ERDEC Scientific Conference on Chemical and Biological Defense Research. D.A. Berg, Ed. :535-541. Research and Technology Directorate, Aberdeen Proving Ground, MD.
97. 97. FLOERSHEIM, G.L. 1992. Calcium antagonists protect mice against the lethal effects of ionizing radiation. Brit. J. Radiol. 65: 1025-1029.
98. 98. FLOERSHEIM, G.L. & C. RACINE. 1995. Calcium antagonist radioprotectors do not reduce radiotherapeutic efficacy in three human tumor xenografts. Strahlenther. Onkol. 171: 403-407.
99. 99. GRACHEV, S.A., A.G. SVERDLOV, N.G. NIKANOROVA, O.I. BOL'SHAKOVA & I.K. KOROLVA. 1994. Decrease of toxic effects of aminothiol radiation-protective agents and increase of chemical protection action against ionizing radiation by the use of unithiol (Russian). Radiats. Biol. Radioecol. 34: 424-429.